TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BioNordika (Sweden) AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
58,446
|
61,115
|
50,824 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
4,110
|
6,461
|
6,883 |
| EBITDA |
4,284
|
6,485
|
7,117 |
| Total assets |
14,766
|
15,733
|
18,980 |
| Current assets |
13,203
|
14,015
|
18,304 |
| Current liabilities |
9,298
|
10,530
|
14,367 |
| Equity capital |
5,468
|
5,203
|
4,612 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
14
|
14
|
13 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
37.0%
|
33.1%
|
24.3% |
| Turnover per employee |
4,175
|
4,365
|
3,910 |
| Profit as a percentage of turnover |
7.0%
|
10.6%
|
13.5% |
| Return on assets (ROA) |
27.8%
|
41.1%
|
36.3% |
| Current ratio |
142.0%
|
133.1%
|
127.4% |
| Return on equity (ROE) |
75.2%
|
124.2%
|
149.2% |
| Change turnover |
-3,771
|
6,685
|
-3,155 |
| Change turnover % |
-6%
|
12%
|
-6% |
| Chg. No. of employees |
0
|
1
|
1 |
| Chg. No. of employees % |
0%
|
8%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.